Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Becton, Dickinson Unveils ESG Strategy for 2030

10/18/2021 | 07:44am EST

By Chris Wack

Becton, Dickinson and Co. on Monday said it is implementing a new strategy to advance environmental, social and governance initiatives for 2030 and beyond.

Becton said it is prioritizing climate change through reducing emissions and integrating climate impact considerations into its business strategy, while also addressing the impact of its products and resiliency of the supply chain. The company recently signed onto the U.N.'s Race to Zero campaign, where it now joins the largest alliance dedicated to achieving net zero carbon emissions by 2050 or sooner.

Its 2030 goals include reducing Scope 1 and 2 greenhouse gas emissions 46% by 2030 from a 2019 baseline and achieving carbon neutrality across direct operations by 2040. The company also committed to set targets to reduce Scope 3 emissions.

The company also plans to reduce the environmental impact of its product portfolio by addressing plastic and packaging material consumption and the impact of plastics throughout its value chain through considerations in product design.

Becton said it plans to report information around performance and progress toward its ESG goals through its annual sustainability report, in alignment with recognized external ESG reporting frameworks.

The company said it continues in its commitment to help achieve the United Nations' Sustainable Development Goals.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

10-18-21 0944ET

All news about BECTON, DICKINSON AND COMPANY
05:44aBD Selects 'embecta' as Name of New Company for Planned Spinoff of Diabetes Care Busine..
AQ
12/06Becton, Dickinson and Company Selects "embecta" as Name for Diabetes Care Unit
MT
12/06Becton, Dickinson and Company Announces management appointments for embecta
CI
12/06Becton, Dickinson and Company Announces New Company Embecta
CI
12/02U.S. OMICRON PLAN : boosters, free at-home tests, tighter travel rules
RE
12/02Becton, Dickinson and Co. Buys Venclose for Undisclosed Sum
MT
12/02BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
PR
12/02Becton, Dickinson and Company acquired Venclose, Inc.
CI
12/01BD Issues 2021 Global Inclusion, Diversity and Equity Report
PR
11/30Becton, Dickinson Says Rapid Antigen, PCR Tests Capable of Detecting Omicron Variant
MT
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 19 416 M - -
Net income 2022 2 337 M - -
Net Debt 2022 13 262 M - -
P/E ratio 2022 31,8x
Yield 2022 1,51%
Capitalization 71 108 M 71 108 M -
EV / Sales 2022 4,35x
EV / Sales 2023 4,03x
Nbr of Employees 75 000
Free-Float 77,5%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | BDX | US0758871091 | MarketScreener
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 250,36 $
Average target price 273,38 $
Spread / Average Target 9,20%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Chris DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY0.06%69 910
ABBOTT LABORATORIES20.99%234 245
MEDTRONIC PLC-5.89%148 224
HOYA CORPORATION25.65%58 349
DEXCOM, INC.41.85%50 829
ALIGN TECHNOLOGY, INC.19.56%50 381